Theravance Biopharma, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12B
10-12B/A
10-K
10-Q
10-Q/A
144
3
3/A
4
4/A
424B5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
EFFECT
FWP
PRE 14A
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-12B/A | 10-12B/A | 0001047469-14-004381 | Apr 30, 2014 | — |
| 10-12B/A | 10-12B/A | 0001047469-14-003560 | Apr 8, 2014 | — |
| 10-12B/A | 10-12B/A | 0001047469-13-010796 | Nov 22, 2013 | — |
| CORRESP | — | 0001104659-13-086671 | Nov 22, 2013 | — |
| UPLOAD | — | 0000000000-13-062336 | Nov 13, 2013 | — |
| 10-12B/A | 10-12B/A | 0001047469-13-010050 | Oct 29, 2013 | — |
| CORRESP | — | 0001104659-13-078814 | Oct 29, 2013 | — |
| UPLOAD | — | 0000000000-13-055797 | Oct 9, 2013 | — |
| 10-12B/A | 10-12B/A | 0001047469-13-009371 | Sep 27, 2013 | — |
| CORRESP | — | 0001104659-13-072723 | Sep 27, 2013 | — |
| UPLOAD | — | 0000000000-13-047846 | Aug 30, 2013 | — |
| 10-12B | 10-12B | 0001047469-13-007989 | Aug 1, 2013 | — |